Editas Medicine Inc (EDIT)
5.40
-0.16
(-2.88%)
USD |
NASDAQ |
May 10, 11:16
Editas Medicine 1 Year Total Returns (Daily): -45.89% for May 9, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 09, 2024 | -45.89% |
| May 08, 2024 | -47.66% |
| May 07, 2024 | -41.86% |
| May 06, 2024 | -42.07% |
| May 03, 2024 | -32.18% |
| May 02, 2024 | -28.59% |
| May 01, 2024 | -34.10% |
| April 30, 2024 | -36.15% |
| April 29, 2024 | -34.19% |
| April 26, 2024 | -32.66% |
| April 25, 2024 | -32.21% |
| April 24, 2024 | -32.02% |
| April 23, 2024 | -33.25% |
| April 22, 2024 | -31.54% |
| April 19, 2024 | -32.14% |
| April 18, 2024 | -31.14% |
| April 17, 2024 | -31.42% |
| April 16, 2024 | -22.92% |
| April 15, 2024 | -19.89% |
| April 12, 2024 | -2.36% |
| April 11, 2024 | -1.94% |
| April 10, 2024 | 0.00% |
| April 09, 2024 | 1.30% |
| April 08, 2024 | -2.89% |
| April 05, 2024 | -1.90% |
| Date | Value |
|---|---|
| April 04, 2024 | -2.30% |
| April 03, 2024 | -3.11% |
| April 02, 2024 | -5.24% |
| April 01, 2024 | 0.41% |
| March 28, 2024 | 4.36% |
| March 27, 2024 | -0.13% |
| March 26, 2024 | -3.22% |
| March 25, 2024 | -1.34% |
| March 22, 2024 | 2.33% |
| March 21, 2024 | -2.73% |
| March 20, 2024 | -3.41% |
| March 19, 2024 | -7.41% |
| March 18, 2024 | -7.77% |
| March 15, 2024 | -3.56% |
| March 14, 2024 | -3.32% |
| March 13, 2024 | 1.90% |
| March 12, 2024 | 9.96% |
| March 11, 2024 | 14.94% |
| March 08, 2024 | 4.21% |
| March 07, 2024 | 2.67% |
| March 06, 2024 | 5.95% |
| March 05, 2024 | 2.01% |
| March 04, 2024 | 10.71% |
| March 01, 2024 | 20.76% |
| February 29, 2024 | 11.28% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-79.67%
Minimum
Sep 02 2022
206.9%
Maximum
Mar 16 2021
-6.47%
Average
-17.37%
Median
May 17 2023
1 Year Total Returns (Daily) Benchmarks
| Vertex Pharmaceuticals Inc | 21.51% |
| Bristol-Myers Squibb Co | -31.38% |
| Regeneron Pharmaceuticals Inc | 28.23% |
| Cabaletta Bio Inc | 2.78% |
| Moderna Inc | -8.28% |